JDD June 2025 Issue Highlights | Special Focus: Acne & Rosacea
acneThe June 2025 issue of the Journal of Drugs in Dermatology delivers a diverse and thought-provoking selection of studies that place a spotlight on acne and rosacea while spanning the latest innovations and clinical insights across the dermatology spectrum. This month’s editor’s picks feature new approaches to some of the field’s most common—and challenging—conditions, from acne-induced …
acne
JDD Buzz Series | GLP-1 Agonists and Isotretinoin
GLP-1 Agonists and IsotretinoinUse of GLP-1 agonists is becoming increasingly more common in the U.S. According to a 2024 poll, one in eight adults has at least tried this medication class. A brief communication published in the June Journal of Drugs in Dermatology shares concerns that could arise when a patient is concurrently on a GLP-1 agonist and isotretinoin. I interviewed author Travis W. Blalock, MD, FAAD, FACMS, dire …
GLP-1 Agonists and Isotretinoin
Dark Spot Actives, Vitamin A Derivatives, and Cleansers: A Brief Review
Vitamin ALeslie Rank, PhD, Global Product Development Lead of Facial Treatment Products, and Rachel Bechtel, Senior Scientist on the Facial Cleansing Product & Process Innovation Team at Kenvue, spoke to dermatology residents at The George Washington University’s first Lab to Label Conference, about the formulation of popular products including dark spot actives, vitamin A derivatives, and cleansers. …
Vitamin A
Pediatric Dermatology: Educational Opportunities for Residents
Pediatric DermatologyPediatric dermatology exposure varies widely between residency programs. While some residents may plan to pursue a pediatric dermatology fellowship, the majority will not. Despite this, most dermatologists will see a mixture of children and adolescents in their clinic. Whether you plan to focus on complex medical dermatology, general dermatology, procedural work, or anything in between, developing …
Pediatric Dermatology